Pathology Trade Group 2nd To Sue FDA Over Lab-Test Rule

By Mark Payne · August 20, 2024, 3:41 PM EDT

A molecular pathology trade group has filed a lawsuit against the U.S. Food and Drug Administration, challenging a recent final rule to regulate laboratory-developed tests as medical devices and arguing the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Association for Molecular Pathology et al v. United States Food and Drug Administration et al

Case Number

3:24-cv-00241

Court

Texas Southern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 19, 2024

Recent Articles By Mark

October 29, 2024
Senate Panel Targets 'Clever' Pharma Pricing
October 29, 2024
HHS Hospital Pay Formula At High Court: 4 Things To Know
October 29, 2024
Latham Partner Brings Clerk Lessons To Hospital Pay Case
October 22, 2024
Medicare Advantage Star Ratings Lawsuits: 3 Things to Know
October 16, 2024
Feds Say EMTALA Trumps Idaho Abortion Ban In Emergencies
October 09, 2024
Montana High Court Upholds Temporary Abortion Ban Blocks
October 08, 2024
Lawmakers, Alcohol Industry Probe HHS Over Alcohol Recs
October 07, 2024
Justices Won't Hear Kickback Statute 'Willfulness' Case
October 07, 2024
High Court Won't Hear Emergency Care Abortion Case
October 01, 2024
11th Circ. Hearsay Ruling May Open Door To Top Court Review